Anti-osteoporosis Medication Monitoring and Management Service
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02194647|
Recruitment Status : Completed
First Posted : July 18, 2014
Last Update Posted : September 4, 2015
One-year adherence to oral anti-osteoporosis medication (AOMs) was only about 30%. In recent years, efforts have been made to change the delivery of these medications from oral form to injection form every, 3, 6 or 12 months to increase adherence. However, both patients and providers are sometimes confused about the multiple choices. Also, patients may receive extra medications if providers did not keep tract of their previous AOM uses or patients may changes providers. There were urgent needs to provide AOM monitoring and management services to improve cares.
To establish a anti-osteoporosis medication management service at National Taiwan University Hospital and its BeiHu Branch.
Participating physicians will select those eligible for services and refer to study coordinators. Study coordinators will conduct baseline assessments on osteoporosis/fracture risks, record medical conditions, AOMs, provide educations on osteoporosis, fracture, sarcopenia, fall, medications, nutrition, and exercise. They also arrange return clinic visit, telephone reminder and follow up for patients, and communicate with providers on regular bases. the investigators plan to enroll 500 patients with 18-month follow up for each.
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||500 participants|
|Official Title:||Anti-osteoporosis Medication Monitoring and Management Service|
|Study Start Date :||July 2014|
|Actual Primary Completion Date :||August 2015|
|Actual Study Completion Date :||August 2015|
- medication adherence [ Time Frame: 18 months ]
Medication adherence will be assessed at 4, 8, 12, 18 months after enrollments. Final results will be reported at 18 month. If the patient changes medication, all AOMs adherence will be combined.
Specific formula is as below:
for oral medications, adherence is defined as # medication taken/ #medication prescribed within past 3 months for injection medications, adherence is defined as # of injection/ # of due injection since baseline or last follow up phone call.
Statistics: Simple counts of adherence % among all participants.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02194647
|National Taiwan University Hospital|
|Taipei, Taiwan, 100|
|Principal Investigator:||Ding-Cheng Chan, MD, PhD||National Taiwan University Hospital|